Advertisement
Collaboration › Details
Bruker–JPMorgan Chase: investor conference, 201801 supply service Bruker presents at JP Morgan Healthcare Conference 2018
Period | 2018-01-08 | |
Region | San Francisco, CA | |
Country | United States (USA) | |
Predecessor | Bruker–JPMorgan Chase: investor conference, 201701 supply service Bruker presents at JP Morgan Healthcare Conference 2017 | |
Successor | Bruker–JPMorgan Chase: investor conference, 201901 supply service Bruker presents at JP Morgan Healthcare Conference 2019 | |
Partner, 1st | Bruker Corporation (Nasdaq: BRKR) | |
Group | Bruker (Group) | |
Partner, 2nd | J.P. Morgan Securities LLC | |
Group | JPMorgan Chase (Group) | |
Product | J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco | |
Product 2 | analytical instrument | |
Person | Laukien, Frank H. (Bruker 201204 President + CEO) | |
Person 2 | Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore) | |
Bruker Corporation. (1/2/18). "Press Release: Bruker Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference". Billerica, MA.
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 36th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Tony Mattacchione, Senior Vice President and CFO will present on behalf of the company on Monday, January 8th, 2018 at 10:00 AM Pacific Time.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's web site at ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com .
Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com
Record changed: 2019-12-10 |
Advertisement
More documents for Bruker (Group)
- [1] NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA....
- [2] Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA....
- [3] Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel....
- [4] Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA....
- [5] Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA....
- [6] Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest ev...
- [7] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
- [8] Bruker Corporation. (10/3/23). "Press Release: Bruker Completes Acquisition of PhenomeX". Billerica, MA....
- [9] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
- [10] Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top